表紙
市場調查報告書

疼痛管理設備:醫療設備的開發平台評估

Pain Management - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 661468
出版日期 內容資訊 英文 322 Pages
訂單完成後即時交付
價格
Back to Top
疼痛管理設備:醫療設備的開發平台評估 Pain Management - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月16日內容資訊: 英文 322 Pages
簡介

本報告提供全球疼痛管理設備的市場上的主要開發中產品及其臨床實驗的進展調查,並彙整產品功能·特性比較分析 (臨床實驗的各進展階段) ,及主要企業·組織的簡介及代表性產品,近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 疼痛管理設備概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 疼痛管理設備:臨床實驗中的開發中產品,各企業

  • 疼痛管理設備的企業:各臨床實驗階段的開發中產品
  • 疼痛管理設備:各臨床實驗階段的開發中產品

第5章 疼痛管理設備市場:企業·產品概要

  • Advanced Amputee Solutions, LLC
  • Advanced Materials Enterprises Co Ltd
  • Algodyne Ltd
  • Algometron Pty Ltd
  • Aptima Inc
  • Avacen Inc
  • BioElectronics Corp
  • Biomet Inc
  • Brown University
  • Cambridge Cognition Holdings plc
  • Cenofex Innovations
  • Children's National Health System
  • CoolSense Medical Ltd.
  • Diavibe, Inc.
  • Emory University
  • Endonovo Therapeutics Inc
  • Gradient Medical Inc
  • GRoK Technologies LLC
  • Hadassah Medical Center
  • Headway
  • IMEXCO General Ltd
  • Immuno-Genic Corporation
  • Intronix Technologies Corporation
  • Lasmed, LLC
  • Mathematical Bio-Solutions Inc.
  • Medovex Corp
  • Myelyx Medical
  • Nativis Inc
  • NeoMedLight
  • NeuroMetrix Inc
  • Nipro
  • Orthovative Technologies
  • Piramal Enterprises Ltd
  • Recovery Force LLC
  • ReGear Life Sciences, Inc.
  • Sea Run Holdings Inc
  • Stanford University
  • Teijin製藥
  • The Sheikh Zayed Institute for Pediatric Surgical Innovation
  • Tyndall National Institute
  • University of California San Diego
  • University of Rochester
  • University of Texas at Arlington
  • University of Texas Medical Branch at Galveston
  • VascuActive Ltd
  • Vertech Inc
  • West Virginia University

第6章 疼痛管理設備市場:目前的趨勢 (全52件)

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0858EPD

GlobalData's Medical Devices sector report, "Pain Management - Medical Devices Pipeline Assessment, 2019" provides an overview of Pain Management currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Pain Management pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Pain Management under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Pain Management and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Pain Management under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 8
  • 1.2 List of Figures 13

2 Introduction 13

  • 2.1 Pain Management Overview 13

3 Products under Development 14

  • 3.1 Pain Management - Pipeline Products by Stage of Development 14
  • 3.2 Pain Management - Pipeline Products by Territory 15
  • 3.3 Pain Management - Pipeline Products by Regulatory Path 16
  • 3.4 Pain Management - Pipeline Products by Estimated Approval Date 17
  • 3.5 Pain Management - Ongoing Clinical Trials 18

4 Pain Management - Pipeline Products under Development by Companies 19

  • 4.1 Pain Management Companies - Pipeline Products by Stage of Development 19
  • 4.2 Pain Management - Pipeline Products by Stage of Development 22

5 Pain Management Companies and Product Overview 24

  • 5.1 Advanced Amputee Solutions, LLC Company Overview 24
  • 5.2 Advanced Materials Enterprises Co Ltd Company Overview 25
  • 5.3 Algodyne Ltd Company Overview 27
  • 5.4 Algometron Pty Ltd Company Overview 28
  • 5.5 AlgometRx Inc Company Overview 29
  • 5.6 Aptima Inc Company Overview 30
  • 5.7 Arbor Medical Innovations LLC Company Overview 31
  • 5.8 Avacen Inc Company Overview 32
  • 5.9 BioElectronics Corp Company Overview 33
  • 5.10 Biomet Inc Company Overview 39
  • 5.11 Brown University Company Overview 42
  • 5.12 Cambridge Cognition Holdings plc Company Overview 43
  • 5.13 CoolSense Medical Ltd. Company Overview 44
  • 5.14 Diavibe, Inc. Company Overview 45
  • 5.15 Ecole Polytechnique Federale de Lausanne Company Overview 46
  • 5.16 EMulate Therapeutics Inc Company Overview 47
  • 5.17 Endonovo Therapeutics Inc Company Overview 48
  • 5.18 Ghent University Company Overview 56
  • 5.19 Gradient Medical Inc Company Overview 57
  • 5.20 GRoK Technologies LLC Company Overview 59
  • 5.21 Hadassah Medical Center Company Overview 60
  • 5.22 H-CYTE Inc Company Overview 61
  • 5.23 Headway Company Overview 63
  • 5.24 IMEXCO General Ltd Company Overview 64
  • 5.25 Immuno-Genic Corporation Company Overview 65
  • 5.26 King Abdullah University of Science and Technology Company Overview 66
  • 5.27 Lasmed, LLC Company Overview 67
  • 5.28 Mathematical Bio-Solutions Inc. Company Overview 70
  • 5.29 Medasense Biometrics Ltd Company Overview 71
  • 5.30 Medifirst Solutions Inc Company Overview 76
  • 5.31 Myelyx Medical Company Overview 78
  • 5.32 NanoVibronix Inc Company Overview 79
  • 5.33 NeoMedLight Company Overview 83
  • 5.34 NeuroMetrix Inc Company Overview 84
  • 5.35 Nipro Corp Company Overview 87
  • 5.36 Nocira LLC Company Overview 88
  • 5.37 Orthovative Technologies Company Overview 89
  • 5.38 Piramal Enterprises Ltd Company Overview 90
  • 5.39 Profound Medical Inc Company Overview 91
  • 5.40 Recovery Force LLC Company Overview 92
  • 5.41 Sao Paulo Research Foundation Company Overview 93
  • 5.42 Sea Run Holdings Inc Company Overview 94
  • 5.43 Stanford University Company Overview 95
  • 5.44 Sublimed SAS Company Overview 96
  • 5.45 Teijin Pharma Ltd Company Overview 99
  • 5.46 The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview 100
  • 5.47 Tyndall National Institute Company Overview 101
  • 5.48 University of British Columbia Company Overview 102
  • 5.49 University of California Irvine Company Overview 103
  • 5.50 University of California San Diego Company Overview 104
  • 5.51 University of Rochester Company Overview 105
  • 5.52 University of Texas at Arlington Company Overview 106
  • 5.53 University of Texas Medical Branch at Galveston Company Overview 107
  • 5.54 University of Utah Company Overview 108
  • 5.55 VascuActive Ltd Company Overview 109
  • 5.56 Vertech Inc Company Overview 110
  • 5.57 ViaTherm Therapeutics LLC Company Overview 111
  • 5.58 West Virginia University Company Overview 113
  • 5.59 ZetrOZ, Inc. Company Overview 114

6 Pain Management- Recent Developments 116

  • 6.1 Nov 18, 2019: NanoVibronix PainShield device receives unique reimbursement code from Centers for Medicare and Medicaid (CMS) 116
  • 6.2 Nov 18, 2019: U.S. Department of Justice (DOJ) Accepts Oberheiden, P.C. Proposal to Coordinate P-Stim Medicare Fraud Investigations 116
  • 6.3 Nov 15, 2019: SANUWAVE health reports third quarter 2019 financial results 117
  • 6.4 Nov 14, 2019: Studies prove VibraCool reduces opioid use and is 4x more effective for pain than other technologies 119
  • 6.5 Nov 14, 2019: Zynex ranked 18th in revenue growth among medical device companies 119

7 Appendix 317

  • 7.1 Methodology 317
  • 7.2 About GlobalData 320
  • 7.3 Contact Us 320
  • 7.4 Disclaimer 320

List of Tables

  • Table 1: Pain Management - Pipeline Products by Stage of Development
  • Table 2: Pain Management - Pipeline Products by Territory
  • Table 3: Pain Management - Pipeline Products by Regulatory Path
  • Table 4: Pain Management - Pipeline Products by Estimated Approval Date
  • Table 5: Pain Management - Ongoing Clinical Trials
  • Table 6: Pain Management Companies - Pipeline Products by Stage of Development
  • Table 7: Pain Management - Pipeline Products by Stage of Development
  • Table 8: Advanced Amputee Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: C.I.E.P. - Product Status
  • Table 10: C.I.E.P. - Product Description
  • Table 11: Advanced Materials Enterprises Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: NanoHeat FIR Flexible Heater - Product Status
  • Table 13: NanoHeat FIR Flexible Heater - Product Description
  • Table 14: NanoHeat IR Flexible Heater - Product Status
  • Table 15: NanoHeat IR Flexible Heater - Product Description
  • Table 16: Algodyne Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: PainGauge - Product Status
  • Table 18: PainGauge - Product Description
  • Table 19: Algometron Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: Algotect Device - Product Status
  • Table 21: Algotect Device - Product Description
  • Table 22: AlgometRx Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: AlgometRx Device - Product Status
  • Table 24: AlgometRx Device - Product Description
  • Table 25: Aptima Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: System For Tracking And Managing Pain - Product Status
  • Table 27: System For Tracking And Managing Pain - Product Description
  • Table 28: Arbor Medical Innovations LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: Multimodal Automated Sensory Testing System - Product Status
  • Table 30: Multimodal Automated Sensory Testing System - Product Description
  • Table 31: Avacen Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: AVACEN 100 - Fibromyalgia - Product Status
  • Table 33: AVACEN 100 - Fibromyalgia - Product Description
  • Table 34: BioElectronics Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: Actipatch - Expanded Indications - Product Status
  • Table 36: Actipatch - Expanded Indications - Product Description
  • Table 37: Allay Menstrual Pain Relief Patch - Product Status
  • Table 38: Allay Menstrual Pain Relief Patch - Product Description
  • Table 39: RecoveryRx - Breast Augmentation(OTC) - Product Status
  • Table 40: RecoveryRx - Breast Augmentation(OTC) - Product Description
  • Table 41: RecoveryRx - Post Operative Edema (OTC) - Product Status
  • Table 42: RecoveryRx - Post Operative Edema (OTC) - Product Description
  • Table 43: BioElectronics Corp - Ongoing Clinical Trials Overview
  • Table 44: Allay Menstrual Pain Relief Patch - Pulsed Electromagnetic Field Treatment for Painful Periods: A Randomized Control Trial
  • Table 45: Actipatch - Expanded Indications - Pulsed Shortwave Therapy (PSWT) Chronic Low Back Pain
  • Table 46: Biomet Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: nSTRIDE APS Kit - Product Status
  • Table 48: nSTRIDE APS Kit - Product Description
  • Table 49: Biomet Inc - Ongoing Clinical Trials Overview
  • Table 50: nSTRIDE APS Kit - A Multicenter, Double-blind, Randomized, Placebo-controlled Pilot Study of a Single, Intra-articular Injection of Autologous Protein Solution (APS) in Patients with Osteoarthritis (OA) of the Knee
  • Table 51: nSTRIDE APS Kit - A Multicenter, Double-blind, Randomized, Saline-controlled Study of a Single, Intra-articular Injection of Autologous Protein Solution in Patients with Knee Osteoarthritis
  • Table 52: nSTRIDE APS Kit - A Two-phase, Multicenter, Randomized Study Comparing Autologous Protein Solution with Hyaluronic Acid Intra Articular Injections in Patients with Knee Osteoarthritis
  • Table 53: Brown University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: Pain Management Device - Product Status
  • Table 55: Pain Management Device - Product Description
  • Table 56: Cambridge Cognition Holdings plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: NeuroVocalix - Product Status
  • Table 58: NeuroVocalix - Product Description
  • Table 59: CoolSense Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: MigraSense - Product Status

List of Figures

  • Figure 1: Pain Management - Pipeline Products by Stage of Development
  • Figure 2: Pain Management - Pipeline Products by Territory
  • Figure 3: Pain Management - Pipeline Products by Regulatory Path
  • Figure 4: Pain Management - Pipeline Products by Estimated Approval Date
  • Figure 5: Pain Management - Ongoing Clinical Trials
Back to Top